Delivery Order SPE2DB20D1109-SPE2DB22FN99A
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,441.01 delivery order is for the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S" and has an ultimate completion date of January 18, 2022. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award is for the delivery of the pharmaceutical product XULANE (150-35 MCG/DAY PATCH 3S) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $2,604.26. The contract has an ultimate completion date of May 22, 2024 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The $1,612.53 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive patch, with a period of performance through January 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA). The contract, valued at $1,059.88, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award is a delivery order contract with a firm fixed price, and the ultimate completion date is June 21, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,296.71 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive drug product. The contract has an ultimate completion date of May 23, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,637.57 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product used in healthcare. The contract has a completion date of June 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,019.04 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major supplier of pharmaceuticals and medical supplies to the U.S. government, through its Corporate Office division. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S. The $13,098.39 firm fixed price contract has an ultimate completion date of April 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The federal contract award is for the pharmaceutical product Xulane 150-35 MCG/DAY Patch, delivered to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,148.69 firm-fixed-price delivery order has a completion date of January 11, 2023, and was awarded on January 10, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,075.04 firm fixed-price delivery order is for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The ultimate completion date for this award is February 22, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FN99ADelivery Order
This federal contract award is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA). The $13,565.21 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on April 11, 2022. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits, in support of military and veteran healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 4/11/22 |